Brand-name vs compounded
Enhance MD vs Ro.co: Brand-Name or Compounded? (2026)
Enhance MD $49/mo, Ro.co $39/mo. What each 2026 program includes, what it omits, and which patient each one suits.
Published · Pricing as published in our provider dataset, synced · Editorial scores 8.4 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Enhance MD versus Ro.co is a common shortlist, and it is a more interesting one than the two homepages suggest.
Choosing between them is really choosing between an approved finished drug and a compounded preparation. Ro.co sits on one side of that line and Enhance MD on the other, and no amount of feature comparison makes the distinction go away.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $49/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- Enhance MD — Tirzepatide at $99/mo; the other side publishes semaglutide only.
- Widest medication choice
- Enhance MD — compounded semaglutide and compounded tirzepatide.
Enhance MD vs Ro.co: the specification
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Enhance MD | Ro.co | |
|---|---|---|
| Advertised price | Semaglutide from $49, tirzepatide from $99, first month | Get started online for $39 |
| Rate after promotions | $49/mo | $39/mo |
| Pricing structure | Flat rate at every dose | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| Support model | No coaching program stated | Provider check-ins included |
| Shipping | Home delivery | Home delivery |
| Price transparency | Partly published | Partly published |
| Tirzepatide | $99/mo | Not published |
| Patient reviews | 10,482 | 40,215 |
| eRxDoctor score | 8.4/10 | 7.5/10 |
Cost over a full course of treatment
Both providers lead with a number designed to get you through the intake. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Enhance MD | Ro.co | |
|---|---|---|
| First month | $49 | $39 |
| Months 2 onward | Not published | Not published |
| 6-month total | Not computable | Not computable |
| 12-month total | Not computable | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Enhance MD and Ro.co: the ongoing flat rate is higher than the $49 introductory month and is not prominently published before intake and ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
Approved medication or compounded preparation
Ro.co dispenses FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables: an approved finished drug, meaning the agency has reviewed both the evidence behind it and the facility that makes it.
Across from that, Enhance MD offers compounded semaglutide and compounded tirzepatide — prepared by a pharmacy rather than manufactured under approval. The price advantage and the reduced oversight are the same fact seen from two sides.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, Enhance MD exists for a reason.
Enhance MD in detail
Enhance MD offers semaglutide from $49 and tirzepatide from $99 for your first month, with flat-rate pricing that stays the same at every dose, no fee escalation. What it is really selling here is the lowest first month anywhere on this list, on both compounds.
Practically: online intake, home delivery, and a pricing model that is flat rate at every dose.
10,000+ patients treated. The formulary covers compounded semaglutide and compounded tirzepatide.
Enhance MD pros
- No hidden fees at higher doses
- Both semaglutide and tirzepatide available on one platform
- 10,000+ patients treated, meaningful real-world clinical volume
- Cheapest first month for both compounds, semaglutide from $49 and tirzepatide from $99
Enhance MD cons
- Ongoing flat-rate pricing not always prominently published before intake
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- The $49/$99 rates are first-month introductory prices; ongoing flat rate is higher
Where it gives ground to Ro.co: what you pay in month two is the number that is missing.
Inside the Ro.co program
Get Started Online for Just $39 Against Enhance MD, that puts it in the position of the cheaper option.
Intake is online consultation. Fulfillment is home delivery. The commercial terms are promotional first month, then standard rate, partly published.
Support: established full-service platform with clinician oversight. The medications on offer are FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- No hidden fees; pricing disclosed before you complete your consultation
- Established, full-service platform with strong brand trust
- FDA-approved finished medication, not compounded
- Get started online for just $39
Ro.co cons
- Less price-competitive than compounded-only platforms for budget-driven patients
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Ongoing medication pricing varies and can be high depending on the plan
Read next to Enhance MD, the weak point: an FDA-approved finished medication costs multiples of a compounded vial.
Who each program is actually built for
Choose Enhance MD if:
- you want to start on their timeline: online intake
- delivery works the way you want it to: home delivery
- you want the price you sign up at to survive titration
- you want tirzepatide available without changing provider later
Choose Ro.co if:
- you would get real value from the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all
- the level of clinical contact suits you: established full-service platform with clinician oversight
- the monthly rate is the constraint — $39/mo against $49/mo
- you want an FDA-approved finished medication rather than a compounded preparation
Where each program concedes something
On price. $39/mo against $49/mo. Enhance MD is asking you to pay for the lowest first month anywhere on this list, on both compounds; decide whether that is a line item you will use.
On access. Enhance MD advertises online intake and home delivery; Ro.co advertises online consultation and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. The pricing structures differ (flat rate at every dose versus promotional first month, then standard rate), and structure, not headline rate, determines the twelve-month bill.
On clinical contact. The support models differ — 10,000+ patients treated against established full-service platform with clinician oversight — and that difference is felt in week two, not week one.
The medication, not the platform
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
STEP 1 recorded a mean 14.9% reduction in body weight over 68 weeks on weekly semaglutide, against 2.4% for placebo, per NEJM, STEP 1.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Enhance MD vs Ro.co: common questions
What happens when Enhance MD's promotional price ends?
The ongoing flat rate is higher than the $49 introductory month and is not prominently published before intake. Ask for it before the first charge, since it governs almost the entire cost of a year of treatment.
Which has more patient reviews, Enhance MD or Ro.co?
Ro.co, with 40,215 against 10,482. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Enhance MD or Ro.co take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Is Enhance MD or Ro.co better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. Ro.co publishes established full-service platform with clinician oversight, which is the more useful thing to buy at the start.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both Enhance MD and Ro.co price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
Are Enhance MD and Ro.co legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Enhance MD operates on flat rate at every dose with pricing partly published, Ro.co on promotional first month, then standard rate, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Enhance MD's case is the lowest first month anywhere on this list, on both compounds; its cost: what you pay in month two is the number that is missing.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Enhance MD vs TMatesBudget vs premium
- Enhance MD vs Elevate HealthBudget vs premium
- Directmeds vs Ro.coBrand-name vs compounded
- Measured vs Ro.coBrand-name vs compounded
- Ro.co vs He & She MDBrand-name vs compounded
- Ro.co vs TMatesBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Enhance MD or Ro.co, and does not sell treatment. Read our ranking methodology.